XOLAIR (Omalizumab) Outcomes in Pediatric Allergic Asthma Patients in the United States
Condition: Asthma Intervention: Drug: Omalizumab Sponsor: Novartis Pharmaceuticals Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 14, 2021 Category: Research Source Type: clinical trials
